At yesterday’s Oncology Innovation Day, Pfizer laid out its business strategy which includes building up its biologics business, specifically antibody-drug conjugates and bispecific antibodies.
Tag Archive for: Blockbusters
A late-stage study of two rheumatoid arthritis drugs from Bristol Myers Squibb (BMY.N) and Johnson & Johnson (JNJ.N) showed a significant drop in deaths among hospitalized COVID patients, a U.S. health agency said on Thursday.
Janssen Pharmaceutical shared positive updates from ongoing trials on candidate therapies for Crohn’s disease (CD) and ulcerative colitis (UC) at Digestive Disease Week in San Diego, California.
R&D/Pipelines Report 2022: Innovating to turn the tide
BioNTech, BNT162b2 (Pfizer and BioNTech), Cancer Cells, CoronaVac (Sinovac Biotech), Covaxin (Bharat Biotech and ICMR), COVID-19 Vaccines, Eli Lilly, February 2022, Issue Archives, Janssen COVID-19 Vaccine (J&J), Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pfizer, Product Pipelines, R&D, Sinopharm, Sinovac, Special Reports, Sputnik Light, Sputnik V vaccine, T-Cells, Therapeutics, Top 10 Pipelines, Vaxzevria (previously COVID-19 Vaccine AstraZeneca), ZyCoV-D (Zydus Cadila)The world’s leading COVID-19 vaccine and therapeutic manufacturers continue to develop treatments for the waves of variants as well as life-changing therapies for disease areas outside the world of coronaviruses. The world’s efforts to combat the global pandemic continue to evolve, as does Coronavirus Disease 2019 as variants and subvariants constantly toss volleys of grenades at the battlefront lines.
